SCHEMBL25832175

SCHEMBL25832175

Cc1ccc2c(c1)C(=O)CC1(CCCCC1)C2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.52
ATM Q13315 3/20 0.52
HTT P42858 1/20 0.52
MEN1 O00255 1/20 0.40
MAPK1 P28482 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HTR1A P08908 4/20 0.40
ADRA1B P35368 3/20 0.40
ADRA1A P35348 2/20 0.40
METAP1 P53582 2/20 0.39
ACHE P22303 1/20 0.39
PARP1 P09874 1/20 0.38
PARP10 Q53GL7 1/20 0.38
RAD52 P43351 1/20 0.38
PGR P06401 1/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
ALDH1A1 P00352 1/20 0.36
F2 P00734 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26052583 0.84 PARP10 (0.43) KDM4EATMHTTMETAP1ACHE
SCHEMBL444593 0.75 TDP1 (0.39) MEN1MAPK1KMT2ANPSR1HTR1A
SCHEMBL8599412 0.75 KDM4E (0.54) KDM4EATMHTTKMT2AMETAP1
SCHEMBL8601620 0.73 KDM4E (0.53) KDM4EATMHTTMETAP1ACHE
SCHEMBL10177012 0.72 MAOA (0.59) KDM4EATMHTTMEN1MAPK1
SCHEMBL29673118 0.72 MAOA (0.59) KDM4EATMHTTMEN1MAPK1
SCHEMBL1274936 0.72 MAOA (0.59) KDM4EATMHTTMEN1MAPK1
SCHEMBL354988 0.71 PBRM1 (0.59) METAP1ACHEPARP1PARP10MAOA
SCHEMBL30465799 0.71 PBRM1 (0.59) METAP1ACHEPARP1PARP10MAOA
SCHEMBL25832189 0.70 ACAT2 (0.39) KDM4EATMHTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702427-B2 Substituted 2-pyridone tricyclic compounds, analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702427-B2 Substituted 2-pyridone tricyclic compounds, analogues thereof, and methods using same HAVCR2, HPD, CYP24A1 KDM4E 1165/4885ATM 4637/4885HTT 670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.